There's no competition
Restrictions continue to rise for many GIP and GLP-1 medications: In 2025, over 82% of people with insurance plans that offer coverage for Wegovy, Zepbound, and Saxenda will encounter restrictions, like prior authorization or step therapy, that make access difficult
Glutathione injections/IV push to do it all, from brightening the skin to boosting energy and so much more
Subjective tracking Energy levels, particularly during fasted states, often improve with effective AOD-9604 protocols
Roughly 32% of tirzepatide-treated participants achieved 25% weight loss, versus 16% in the semaglutide arm
Glutathione, in particular, can support healthy memory ability and healthy cognitive function